News Zhejiang Medicine Co., Ltd.

Equities

600216

CNE0000010J2

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
9.33 ^CNY	+0.21%		+1.41%	-13.05%

2023	Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug	MT
2023	Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug	Nov. 28	MT
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Zhejiang Medicine Wins Nod to Trial Anti-Tumor Drug	23-09-19	MT
Zhejiang Medicine’s South Korean Unit Clears Good Manufacturing Practice Inspection	23-08-23	MT
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Citic Securities says global financial market fluctuations hurt business	23-03-30	RE
Zhejiang Medicine to Market Antibiotic in the US After Getting FDA Nod; Shares Jump 3%	23-01-30	MT
Zhejiang Medicine Co., Ltd.(SHSE:600216) dropped from Shanghai Stock Exchange Health Care Sector Index	22-12-09	CI
Zhejiang Medicine Unit Gets Clinical Trial Approval For Anti-Biliary Tract Cancer Drug	22-11-01	MT
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Brokerage CLSA vice-chairman Charles Lin resigns	22-09-26	RE
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Zhejiang Medicine Co., Ltd.(SHSE:600216) added to Shanghai Stock Exchange Health Care Sector Index	22-06-13	CI
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
TaiGen Biopharmaceuticals Turns to Profit in 2021	22-03-17	MT
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Zhejiang Medicine Co., Ltd.(SHSE:600216) dropped from Shanghai Stock Exchange Health Care Sector Index	21-06-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Medicine Co., Ltd.

Equities

600216

CNE0000010J2

Summary

Filters